Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trialJianxing He, Caicun Zhou, Chunxia Su et al.|The Lancet Respiratory Medicine|2021Cited by 183
Ricolinostat (ACY-1215) suppresses proliferation and promotes apoptosis in esophageal squamous cell carcinoma via miR-30d/PI3K/AKT/mTOR and ERK pathwaysJinglin Cao, Jian Hu|Cell Death and Disease|2018Cited by 83
The Society for Translational Medicine: clinical practice guidelines for the postoperative management of chest tube for patients undergoing lobectomyShugeng Gao, Yousheng Mao, Zhongheng Zhang et al.|Journal of Thoracic Disease|2017Cited by 58
Metformin reverses chemoresistance in non-small cell lung cancer via accelerating ubiquitination-mediated degradation of Nrf2Sha Huang, Jian Hu|Translational Lung Cancer Research|2020Cited by 56
Schizandrin A can inhibit non‑small cell lung cancer cell proliferation by inducing cell cycle arrest, apoptosis and autophagyLinhai Zhu, Jian Hu|International Journal of Molecular Medicine|2021Cited by 42